Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Gross Margin: 2020-2024

Historic Gross Margin for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to 62.81%.

  • Journey Medical's Gross Margin fell 208.00% to 67.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 66.05%, marking a year-over-year decrease of 201.00%. This contributed to the annual value of 62.81% for FY2024, which is 828.00% down from last year.
  • As of FY2024, Journey Medical's Gross Margin stood at 62.81%, which was down 11.65% from 71.09% recorded in FY2023.
  • In the past 5 years, Journey Medical's Gross Margin registered a high of 71.09% during FY2023, and its lowest value of 49.18% during FY2021.
  • Moreover, its 3-year median value for Gross Margin was 62.81% (2024), whereas its average is 64.04%.
  • In the last 5 years, Journey Medical's Gross Margin plummeted by 1,805bps in 2021 and then soared by 1,286bps in 2023.
  • Yearly analysis of 5 years shows Journey Medical's Gross Margin stood at 67.23% in 2020, then tumbled by 1,805bps to 49.18% in 2021, then surged by 904bps to 58.23% in 2022, then surged by 1,286bps to 71.09% in 2023, then tumbled by 828bps to 62.81% in 2024.